Article
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology - 1 Mar 2021
Al-Sheikh Abrar, Yousef Al-Motassem, Alshamaseen Daniah, Farhad Rand
Abstract excerpt
BACKGROUND: High-dose methotrexate (HD- MTX) is the cornerstone of chemotherapy for acute lymphoblastic leukemia (ALL), and one of its target enzymes is Thymidylate Synthase (TYMS). We hypothesized that genetic polymorphisms of TYMS gene would be associated with MTX toxicity in ALL children. METHODS: 64 children with ALL were included in this study. Genotyping analysis was conducted on three common polymorphisms:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
